BG Medicine (BGMD) Posts Quarterly Results
BG Medicine (NASDAQ:BGMD) released its earnings data on Thursday. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06), American Banking News.com reports. The company had revenue of $2.20 million for the quarter, compared to the consensus estimate of $1.40 million.
Shares of BG Medicine (NASDAQ:BGMD) opened at 0.94 on Thursday. BG Medicine has a 52 week low of $0.55 and a 52 week high of $2.42. The stock has a 50-day moving average of $0.99 and a 200-day moving average of $1.21. The company’s market cap is $32.3 million.
BG Medicine, Inc (NASDAQ:BGMD) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.